Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X

Abstract

Endothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta blocker, on endothelial function in CSX patients.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By